↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Czech Republic NEN contract award · ocds-ted-100715-2026

Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek pro autologní buněčnou terapii - brexukabtagen a

Fakultní nemocnice Plzeň awarded Kč109M to Gilead Sciences s.r.o. for Professional Services & Consulting in February 2026 — one of 777 awards this buyer has made, above its typical award size.

Professional Services & Consulting
12 Feb 2026
Award date
Kč109M
Contract value

Buying agency

Fakultní nemocnice Plzeň
777 Awards
Kč17.9M Avg award
Above vs typical

Winning supplier

Gilead Sciences s.r.o.
71 Awards
24 Buyers
Kč3.2B Total won

Contract description

Czechia – Antineoplastic and immunomodulating agents – Léčivý přípravek pro autologní buněčnou terapii - brexukabtagen autoleucel - 2025

Premium

Related awards · Fakultní nemocnice Plzeň

777 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

733 more awards from this buyer · full history & CSV export

Premium

Other wins · Gilead Sciences s.r.o.

71 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Fakultní nemocnice Plzeň and Gilead Sciences s.r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up